<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Barik SK</submitter><funding>Indian Council of Medical Research, Govt. of India</funding><pagination>898</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7694411</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Plasma proteins are known to interfere the drug metabolism during therapy. As limited information is available regarding the role of plasma proteins in HIV drug resistance during ART in HIV/AIDS patients, the present study aimed to identify and characterize the differentially expressed plasma proteins in the drug resistant and drug respondent groups of HIV-1 infected patients with > 6 years of first line ART.&lt;h4>Methods&lt;/h4>Four-drug resistant (treatment failure) and four-drug respondent (treatment responder) patients were selected for plasma proteomic analysis based on viral load and drug resistance associated mutations from a cohort study designed on the first line ART patients who were enrolled in the antiretroviral therapy center, Sarojini Naidu Medical College, Agra</pubmed_abstract><journal>BMC infectious diseases</journal><pubmed_title>Identification and differential expression of serotransferrin and apolipoprotein A-I in the plasma of HIV-1 patients treated with first-line antiretroviral therapy.</pubmed_title><pmcid>PMC7694411</pmcid><funding_grant_id>80/990/2015-ECD-I.</funding_grant_id><pubmed_authors>Mohanty KK</pubmed_authors><pubmed_authors>Singh TP</pubmed_authors><pubmed_authors>Gopal G</pubmed_authors><pubmed_authors>Tripathy SP</pubmed_authors><pubmed_authors>Barik SK</pubmed_authors><pubmed_authors>Jena S</pubmed_authors><pubmed_authors>Patil SA</pubmed_authors><pubmed_authors>Bisht D</pubmed_authors><pubmed_authors>Rawat P</pubmed_authors><pubmed_authors>Sharma D</pubmed_authors><pubmed_authors>Mohanty AK</pubmed_authors><pubmed_authors>Singh R</pubmed_authors><pubmed_authors>Tandon R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification and differential expression of serotransferrin and apolipoprotein A-I in the plasma of HIV-1 patients treated with first-line antiretroviral therapy.</name><description>&lt;h4>Background&lt;/h4>Plasma proteins are known to interfere the drug metabolism during therapy. As limited information is available regarding the role of plasma proteins in HIV drug resistance during ART in HIV/AIDS patients, the present study aimed to identify and characterize the differentially expressed plasma proteins in the drug resistant and drug respondent groups of HIV-1 infected patients with > 6 years of first line ART.&lt;h4>Methods&lt;/h4>Four-drug resistant (treatment failure) and four-drug respondent (treatment responder) patients were selected for plasma proteomic analysis based on viral load and drug resistance associated mutations from a cohort study designed on the first line ART patients who were enrolled in the antiretroviral therapy center, Sarojini Naidu Medical College, Agra</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Nov</publication><modification>2026-05-01T00:59:30.87Z</modification><creation>2021-02-20T03:04:36Z</creation></dates><accession>S-EPMC7694411</accession><cross_references><pubmed>33246440</pubmed><doi>10.1186/s12879-020-05610-6</doi></cross_references></HashMap>